The ASH Research Collaborative® (ASH RC) Multiple Myeloma Research Network is pleased to announce the recipients of the Multiple Myeloma Data Hub Award. Following a highly competitive review process that drew many well-qualified applications, three community-based practices were selected to join the Network:
- Endeavor Health’s Evanston, Swedish, Glenbrook, and Highland Park Hospitals
- Rutgers Cancer Institute – RWJBarnabas Health’s New Brunswick, Cooperman, and Newark Beth Israel Hospitals
- Northwell Health Cancer Institute’s Huntington, Phelps, Northern Westchester, South Shore University, Peconic Bay, and Staten Island University Hospitals
In addition, Walter Reed National Military Medical Center will join the Network as a fourth community-based practice.
Expanding the Network to Strengthen Real-World Evidence
The American Society of Hematology (ASH) expanded its awards and mentorship programs to address threats to funding for hematology research and protect the pipeline of new hematologists entering the field. In these extraordinary times, the ASH RC is uniquely positioned to advance ASH’s Fight4Hematology initiative by expanding its Multiple Myeloma Research Network.
With the addition of these four community-based practices, the awardees will join an established Network of 12 academic medical centers participating in the Multiple Myeloma Data Hub, contribute to ongoing real-world data generation efforts, and collaborate with leading institutions working to advance research and improve patient outcomes.
Why Community-Based Practices Matter
Because most patients with multiple myeloma receive their care in community-based practices, expanding participation beyond academic medical centers is essential to more accurately reflect how care is delivered in the real world. The inclusion of community sites will enhance the generalizability of the data and help ensure that the insights generated are meaningful and applicable across a broad range of practice settings.
Integrating these sites strengthens the Network’s ability to generate comprehensive real-world evidence that reflects the full spectrum of patients living with multiple myeloma, including individuals from diverse racial, ethnic, socioeconomic, and geographic backgrounds. Increasing the number and variety of participating sites will expand the volume and breadth of available data, enabling more robust analyses of treatment patterns, care delivery, and outcomes across both academic and community settings.
About the Awardees
Each of the selected community sites demonstrated:
- A strong track record of providing care for patients with multiple myeloma
- Existing clinical research capabilities and experience with multiple myeloma trials
- A broad patient population representative of real-world care
- The ability to contribute electronic health record data to the ASH RC Data Hub
- Institutional commitment to collaborative multiple myeloma research
Looking Ahead
The ASH RC extends its sincere thanks to all institutions that applied and congratulates the awardees on this exciting milestone. Together, these additions mark an important step forward in building a more representative, collaborative, and impactful Multiple Myeloma Research Network.
The American Society of Hematology and ASH RC continue to champion advocacy efforts and support hematologists through the #Fight4Hematology. Join the fight by visiting hematology.org/fight4hematology.
